AGEN
AgenusDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
AGEN vs peer average
35/100
AGEN vs. peer average (D vs. C)
Grade spread
A 3 · B 2 · D 3 · F 3
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
AARD is the first available peer comparator.
Aardvark Therapeutics is a packet-identified same-sector, similar-market-cap biotech comparator, but it should be used only as a small-cap clinical-development and financing-risk reference rather than as a direct BOT+BAL oncology peer.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
AGEN
Agenus
AARD
Aardvark Therapeutics
Grade
D
A
Momentum
86
90
Value
41
46
Sentiment
13
52
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Constructive
Grade position vs AARD
AGEN / AARD
Grade Position
Below peers
AGEN vs. peer average (D vs. C)
35/100
Momentum
86
AARDValue
41
AARDSentiment
13
AARDRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs AGEN
AARD is the first peer returned for this comparison set.